Fabienne Trullemans

509 total citations
20 papers, 362 citations indexed

About

Fabienne Trullemans is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Fabienne Trullemans has authored 20 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Genetics and 5 papers in Oncology. Recurrent topics in Fabienne Trullemans's work include Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Fabienne Trullemans is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Fabienne Trullemans collaborates with scholars based in Belgium, France and United States. Fabienne Trullemans's co-authors include Rik Schots, Rik Schots, Benjamin Van Camp, Ivan Van Riet, M. De Waele, B Van Camp, L. Kaufman, Patrick Lacor, Kristin Jochmans and Wim Renmans and has published in prestigious journals such as Blood, Transplantation and American Journal of Clinical Pathology.

In The Last Decade

Fabienne Trullemans

20 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabienne Trullemans Belgium 12 190 114 64 56 55 20 362
Francesca Nesi Italy 12 163 0.9× 59 0.5× 30 0.5× 66 1.2× 49 0.9× 17 297
Carme Pedro Spain 12 185 1.0× 62 0.5× 59 0.9× 43 0.8× 151 2.7× 27 342
Omar Racchi Italy 11 123 0.6× 105 0.9× 73 1.1× 76 1.4× 100 1.8× 19 463
Shu-Huey Chen Taiwan 14 190 1.0× 97 0.9× 73 1.1× 39 0.7× 103 1.9× 29 426
Nobuyuki Hyakuna Japan 11 148 0.8× 47 0.4× 90 1.4× 79 1.4× 39 0.7× 33 364
K. Towlson United Kingdom 10 183 1.0× 123 1.1× 28 0.4× 106 1.9× 42 0.8× 16 369
Rita Balter Italy 12 92 0.5× 115 1.0× 29 0.5× 46 0.8× 56 1.0× 36 361
Blanca Molina Spain 11 178 0.9× 100 0.9× 44 0.7× 92 1.6× 29 0.5× 31 346
C. F. Lucas United Kingdom 5 178 0.9× 35 0.3× 31 0.5× 40 0.7× 50 0.9× 7 321
J.R. Kendra United Kingdom 9 216 1.1× 46 0.4× 24 0.4× 58 1.0× 43 0.8× 11 319

Countries citing papers authored by Fabienne Trullemans

Since Specialization
Citations

This map shows the geographic impact of Fabienne Trullemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabienne Trullemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabienne Trullemans more than expected).

Fields of papers citing papers by Fabienne Trullemans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabienne Trullemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabienne Trullemans. The network helps show where Fabienne Trullemans may publish in the future.

Co-authorship network of co-authors of Fabienne Trullemans

This figure shows the co-authorship network connecting the top 25 collaborators of Fabienne Trullemans. A scholar is included among the top collaborators of Fabienne Trullemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabienne Trullemans. Fabienne Trullemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghesquières, Hervé, Hervé Tilly, Anne Sonet, et al.. (2017). THE 5‐YEAR FOLLOW‐UP RESULTS OF THE C5R PROTOCOL WITH RITUXIMAB AND INTRATHECAL LIPOSOMAL CYTARABINE FOR PRIMARY CNS LYMPHOMA: A PROSPECTIVE PHASE 2 STUDY OF THE LYSA. Hematological Oncology. 35(S2). 198–199. 2 indexed citations
2.
Devos, Timothy, Pierre Zachée, Dominique Bron, et al.. (2014). Myelofibrosis patients in Belgium: disease characteristics. Acta Clinica Belgica. 70(2). 105–111. 6 indexed citations
3.
4.
Smet, Dieter De, Fabienne Trullemans, Kristin Jochmans, et al.. (2012). Diagnostic Potential of CD34+ Cell Antigen Expression in Myelodysplastic Syndromes. American Journal of Clinical Pathology. 138(5). 732–743. 14 indexed citations
5.
6.
Fontaine, Christel, et al.. (2011). Evaluation of a Comprehensive Rehabilitation Program for Post-Treatment Patients With Cancer. Oncology nursing forum. 38(6). E418–E424. 16 indexed citations
7.
Delforge, Michel, Dominik Selleslag, Philippe Mineur, et al.. (2011). Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes. Annals of Hematology. 90(6). 655–666. 11 indexed citations
8.
Trullemans, Fabienne, et al.. (2009). 1253 Tyrosine kinase inhibitor (TKI)-induced macrocytosis. European Journal of Cancer Supplements. 7(2). 136–136. 1 indexed citations
9.
Trullemans, Fabienne, et al.. (2009). Tyrosine kinase inhibitor-induced macrocytosis.. PubMed. 29(12). 5225–8. 18 indexed citations
10.
Caers, Jo, Isabelle Vande Broek, Hendrik De Raeve, et al.. (2008). Multiple myeloma – an update on diagnosis and treatment. European Journal Of Haematology. 81(5). 329–343. 50 indexed citations
11.
Waele, Marc De, et al.. (2007). CML blast crisis following emergence of Ph negative clones during complete cytogenetic response induced by imatinib. 62(4). 262–262. 3 indexed citations
12.
13.
Waele, M. De, Wim Renmans, Kristin Jochmans, et al.. (2001). Growth factor receptor profile of CD34+ cells in AML and B‐lineage ALL and in their normal bone marrow counterparts. European Journal Of Haematology. 66(3). 178–187. 17 indexed citations
14.
15.
Trullemans, Fabienne, et al.. (2001). Clinical findings and magnetic resonance imaging in severe cyclosporine‐related neurotoxicity after allogeneic bone marrow transplantation. European Journal Of Haematology. 67(2). 94–99. 60 indexed citations
16.
Schots, Rik, Fabienne Trullemans, Ivan Van Riet, et al.. (2000). THE CLINICAL IMPACT OF EARLY GRAM-POSITIVE BACTEREMIA AND THE USE OF VANCOMYCIN AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION. Transplantation. 69(7). 1511–1514. 15 indexed citations
17.
Trullemans, Fabienne, Rik Schots, Guy Storme, & B Van Camp. (2000). Late and localized extramedullary relapse of a light chain kappa myeloma after syngeneic bone marrow transplantation. Bone Marrow Transplantation. 25(1). 115–117. 13 indexed citations
18.
Waele, M. De, Wim Renmans, Kristin Jochmans, et al.. (1999). Different expression of adhesion molecules on CD34+ cells in AML and B‐lineage ALL and their normal bone marrow counterparts. European Journal Of Haematology. 63(3). 192–201. 34 indexed citations
19.
Schots, Rik, L. Kaufman, Ivan Van Riet, et al.. (1998). Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality. Bone Marrow Transplantation. 22(1). 79–85. 42 indexed citations
20.
Waele, Marc De, Wim Renmans, Kristin Jochmans, et al.. (1998). Abberant expression of adhesion molecules on CD34+ cells of acute leukemia. VUBIR (Vrije Universiteit Brussel). 102. 161–161. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Nesi Breakdown of academic impact, for papers by Carme Pedro Breakdown of academic impact, for papers by Omar Racchi Breakdown of academic impact, for papers by Shu-Huey Chen Breakdown of academic impact, for papers by Nobuyuki Hyakuna Breakdown of academic impact, for papers by K. Towlson Breakdown of academic impact, for papers by Rita Balter Breakdown of academic impact, for papers by Blanca Molina Breakdown of academic impact, for papers by C. F. Lucas Breakdown of academic impact, for papers by J.R. Kendra
Rankless by CCL
2026